Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Jun 1;37(6):282-286.
doi: 10.1097/BOT.0000000000002555.

The Use of Vancomycin Powder in Tibial Plateau Fractures at Lower Risk of Infection

Nicolas Zingas  1 , Zachary D Hannan  1 , Kathleen M Healey  1 , Natasha S McKibben  1 , Cynthia E Burke  1 , Phillip C McKegg  1 , Qasim M Ghulam  1 , Nathan N O'Hara  1 , Manjari Joshi  2 , Andrew Dubina  1 , Robert V O'Toole  1
Affiliations
Clinical Trial

The Use of Vancomycin Powder in Tibial Plateau Fractures at Lower Risk of Infection

Nicolas Zingas et al. J Orthop Trauma. .

Abstract

Objective: To determine the effectiveness of vancomycin powder in preventing infection after plate and screw fixation of tibial plateau fractures considered at low risk of infection.

Design: Retrospective cohort study.

Setting: Single, Level I trauma center.

Patients/participants: This study included 459 patients with tibial plateau fractures (OTA/AO 41-B/C) who underwent open reduction and internal fixation from 2006 to 2018 and were considered at low risk of infection based on not meeting the "high risk" definition of the VANCO trial.

Intervention: Vancomycin powder administration on wound closure at the time of definitive fixation.

Main outcome measurements: Deep surgical site infection with at least 1 gram-positive bacteria culture.

Results: Vancomycin powder administration was associated with reduction in gram-positive infection from 4% to 0% (odds ratio, 0.12; 95% confidence interval, 0.04-0.32; P < 0.01). No significant effect was reported in gram-negative only infections, which were observed in 0.3% in the control group, compared with 0.9% in the intervention group (odds ratio, 2.71; 95% confidence interval, 0.11-69; P = 0.54). Methicillin-resistant Staphylococcus aureus was the most common organism isolated in the control group, growing in 9 of 18 infections (50%).

Conclusions: Among patients with low-risk tibial plateau fractures, vancomycin powder at the time of definitive fixation showed a reduction in the incidence of gram-positive deep surgical site infection. The observed relative effect was relatively larger than that observed in a previous randomized trial on high-risk fractures. These data might support broadening the indication for use of vancomycin powder to include tibial plateau fractures at low risk of infection.

Level of evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

PubMed Disclaimer

References

    1. Major Extremity Trauma Research Consortium (METRC). Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. JAMA Surg. 2021;156:e207259.
    1. O'Toole RV, Degani Y, Carlini AR, et al. Systemic absorption and nephrotoxicity associated with topical vancomycin powder for fracture surgery. J Orthop Trauma. 2021;35:29–34.
    1. Balabanova A, Chu X, Chambers LR, et al. Incidence of surgical site infections and acute kidney injuries after topical antibiotic powder application in orthopaedic trauma surgery. J Orthop Trauma. 2021;35:e377–e380.
    1. Kirchner GJ, Smith NP, Garner MR. Intra-wound vancomycin and tobramycin powder for infection prophylaxis in orthopaedic trauma surgery: economically justifiable?. Injury. 2021;52:3340–3343.
    1. National Health Safety Network. Surgical site infection (SSI) event [CDC website]. 2022. Available at: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf . Accessed May 5, 2022.

Publication types

LinkOut - more resources